In the third quarter, Commonwealth Equity Services LLC decreased its position in GE HealthCare Technologies Inc. by 34.4%, selling 91,088 shares and ending the period with 173,486 shares. The transaction reduced the fund’s holding value to approximately $13.0 million. This move contrasts with other institutional investors, such as Mirae Asset Global Investments, which modestly increased its stake by 4.2%, and National Bank of Canada FI, which more than doubled its position by acquiring an additional 514,007 shares during the same period.

GE HealthCare reported third-quarter earnings of $1.07 per share, beating consensus by $0.02, on revenue of $5.14 billion, which was $0.07 billion above estimates. Revenue grew 5.8% year-over-year, driven by strength in diagnostic imaging and services. Return on equity stood at 22.5%, with a net margin of 10.9%. Management reaffirmed full-year 2025 adjusted earnings guidance in a range of $4.51 to $4.63 per share, implying mid-single-digit growth over the prior year’s results.

The board declared a quarterly dividend of $0.035 per share, payable February 13 to shareholders of record as of January 9. This represents an annualized payout of $0.14 per share and a payout ratio of 2.9% based on midpoint guidance. The modest dividend underscores the company’s commitment to returning capital while preserving funds for targeted investments in research and development and service infrastructure upgrades.

Analyst coverage remains balanced, with seven firms assigning buy ratings and seven rating the stock as hold. Recent revisions include an increase in the price objective from $90 to $95 by Stifel Nicolaus and reaffirmed buy ratings by Goldman Sachs and BTIG Research. The consensus target stands at $89.50, reflecting expectations for sustained margin improvement and continued growth in high-margin software and services offerings.